Can Upcoming Catalysts Help Onconova Therapeutics Stock Rebound?

Posted in Biotech

February 03, 2020 • 2 min read

Onconova Therapeutics (Nasdaq: ONTX) has had a rough start to the year with their stock down 35% so far in 2020. The company announced a $10 million stock offering at the end of December, which has continued weighing on the stock even after closing in early January...

Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases

Posted in Biotech

January 27, 2020 • 2 min read

Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, announces new preclinical...